F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $574,000 | -81.0% | 91,761 | -89.2% | 0.00% | -83.3% |
| Q1 2022 | $3,018,000 | -38.7% | 850,000 | -13.4% | 0.01% | -40.0% |
| Q4 2021 | $4,926,000 | -31.4% | 981,249 | 0.0% | 0.02% | -37.5% |
| Q3 2021 | $7,183,000 | -22.2% | 981,249 | -8.7% | 0.03% | -22.0% |
| Q2 2021 | $9,234,000 | +1037.2% | 1,075,000 | +1333.3% | 0.04% | +925.0% |
| Q1 2021 | $812,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |